Fischer Seth H. Z. sold (to issuer) 141,023 shares of ESPR
Fischer Seth H. Z. sold (to issuer) 141,023 shares of Esperion Therapeutics, Inc. (ESPR) on 2026-07-13.
How this was made
The 30-second read
Why it matters
The newest concrete fact is the director’s sale of 141,023 shares to the issuer on 2026-07-13; no price/value or 10b5-1 plan details are provided.
Market read
Traders may note insider selling, but the lack of disclosed price/value and absence of other catalysts makes this low-signal for valuation.
What to watch
Because the price and total value are not disclosed, the economic magnitude and intent are hard to infer; check for related Form 4s around the same date.
Background
The article is an SEC Form 4 insider transaction disclosure for Esperion Therapeutics, Inc.
Ticker impact
Esperion Therapeutics director Fischer Seth H. Z. sold 141,023 shares to the issuer on 2026-07-13, with price undisclosed.
Likely minimal, unless follow-on filings show unusual scale or repeated selling.
Form 4 shows a director role and a sale to issuer, but the filing provides no transaction price/value and no accompanying corporate event or guidance change.
Market effects
No clear sector read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
A sale to the issuer can be administrative or part of a structured program, so it may not reflect bearish expectations.
Key entities
- issuerEsperion Therapeutics, Inc.
Subject of the Form 4 insider transaction disclosure (ESPR).
- insiderFischer Seth H. Z.
Director who sold 141,023 shares to the issuer on 2026-07-13.